(Q31991337)

5 July 2017

title

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study (English)

1 reference

5 July 2017

10

H J Möller

1 reference

5 July 2017

E M Meisenzahl

1

1 reference

5 July 2017

S Dresel

2

1 reference

5 July 2017

T Frodl

3

1 reference

5 July 2017

G J Schmitt

4

1 reference

5 July 2017

U W Preuss

5

1 reference

5 July 2017

B Rossmüller

6

1 reference

5 July 2017

K Tatsch

7

1 reference

5 July 2017

T Mager

8

1 reference

5 July 2017

K Hahn

9

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Journal of Psychopharmacology

5 July 2017

published in

1 reference

5 July 2017

volume

14

1 reference

5 July 2017

issue

4

1 reference

5 July 2017

page(s)

364-370

1 reference

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

High-dose olanzapine for treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

IBZM-SPECT imaging of dopamine D2 receptors with typical and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

In vivo 123 I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400405

10.1177/026988110001400405

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference